The Department of Justice (DOJ) filed an appeal after U.S. District Judge Matthew Kacsmaryk issued an injunction on Friday that temporarily halts the approval of the abortion drug mifepristone, the U.S.’s most common method of abortion. Kacsmaryk’s ruling comes following a lawsuit brought by the Alliance Defending Freedom claiming the Food and Drug Administration (FDA) failed to adequately assess the risks before approving the drug for use. The DOJ wrote in its appeal, “If allowed to take effect, the court’s order would thwart FDA’s scientific judgment and severely harm women, particularly those for whom mifepristone is a medical or practical necessity.” Newsmax reports that some Democrat-run states are stockpiling mifepristone until Kacsmaryk issues a final ruling or the injunction is reversed on appeal.
